A webcast of the decision will be available from the investors/media section of the Company's web site at.. Antares Pharma reports total revenues of $5.2 million for 1st quarter 2014 Antares Pharma, Inc. today reported operating and financial results for the 1st quarter ended March 31, 2014. LEO Pharma brings a devoted sales force of 75 representatives concentrated solely on the treating psoriasis. To day, Antares has received $10 million in milestone payments from LEO Pharma. Announced the issuance of U.S. Patents RE44847 and RE44846. These patents trace back to inventions made in the late 1990's and catch innovations in the field of auto injectors that originally established Antares Pharma's placement as a leader and innovator in medical injection device technology.Biopharmaceuticals offer many advantages such as for example effective and potent actions highly, fewer unwanted effects and the potential to remedy diseases instead of merely deal with the symptoms actually. These advantages, combined with increasing number of fresh diseases which can be treated with biopharmaceuticals, are traveling enhanced production of the drugs world-wide. ‘The biopharmaceuticals market is a rapidly developing sector within the pharmaceuticals sector with immense possibilities and implications for health care,’ remarks Market Analyst Dr.